VINCENCE DILLON: Open Payments
NPI 1437195534 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 43 payments from 14 companies in 2025. Trend: 2023 $238 · 2024 $545 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $99 |
| Corium, LLC | 4 | $92 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| Neurocrine BioSciences, Inc. | 1 | $40 |
| Almatica Pharma LLC | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: REXULTI, CAPLYTA, SPRAVATO, Azstarys, ABILIFY MAINTENA, FANAPT, Jornay PM, Sunosi.
Industry payments across FL — which companies pay providers there.
